• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种正电荷锌酞菁将阿尔茨海默病淀粉样β聚集物转化为无毒低聚物并在培养物中抑制神经毒性。

A Cationic Zn-Phthalocyanine Turns Alzheimer's Amyloid β Aggregates into Non-Toxic Oligomers and Inhibits Neurotoxicity in Culture.

机构信息

Department of Laboratory Medicine, Shimane University Faculty of Medicine, 89-1 Enya Cho, Izumo 693-8501, Japan.

Department of Neurology, Shimane University Faculty of Medicine, 89-1 Enya Cho, Izumo 693-8501, Japan.

出版信息

Int J Mol Sci. 2024 Aug 16;25(16):8931. doi: 10.3390/ijms25168931.

DOI:10.3390/ijms25168931
PMID:39201616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11354870/
Abstract

Amyloid β peptide (Aβ) aggregation and deposition are considered the main causes of Alzheimer's disease. In a previous study, we demonstrated that anionic Zn-phthalocyanine (ZnPc) can interact with the Aβ peptide and inhibit the fibril-formation process. However, due to the inability of anionic ZnPc to cross the intact blood-brain barrier, we decided to explore the interaction of cationic methylated Zn-phthalocyanine (cZnPc) with the peptide. Using a ThT fluorescence assay, we observed that cZnPc dose-dependently and time-dependently inhibited Aβ fibril levels under in vitro fibril-formation conditions. Electron microscopy revealed that it caused Aβ peptides to form small aggregates. Western blotting and dot immunoblot oligomer experiments demonstrated that cZnPc increased rather than decreased the levels of oligomers from the very early stages of incubation. A binding assay confirmed that cZnPc could bind with the peptide. Docking simulations indicated that the oligomer species of Aβ had a higher ability to interact with cZnPc. ANS fluorescence assay results indicated that cZnPc did not affect the hydrophobicity of the peptide. However, cZnPc significantly increased intrinsic tyrosine fluorescence of the peptide after 8 h of incubation in fibril-formation conditions. Importantly, cell culture experiments demonstrated that cZnPc did not exhibit any toxicity up to a concentration of 10 µM. Instead, it protected a neuronal cell line from Aβ-induced toxicity. Thus, our results suggest that cZnPc can affect the aggregation process of Aβ, rendering it non-toxic, which could be crucial for the therapy of Alzheimer's disease.

摘要

淀粉样 β 肽 (Aβ) 的聚集和沉积被认为是阿尔茨海默病的主要原因。在之前的研究中,我们证明了阴离子锌酞菁 (ZnPc) 可以与 Aβ 肽相互作用并抑制纤维形成过程。然而,由于阴离子 ZnPc 无法穿过完整的血脑屏障,我们决定探索阳离子甲基化锌酞菁 (cZnPc) 与肽的相互作用。使用 ThT 荧光测定法,我们观察到 cZnPc 在体外纤维形成条件下剂量依赖性和时间依赖性地抑制 Aβ 纤维水平。电子显微镜显示它导致 Aβ 肽形成小聚集体。Western blot 和斑点免疫印迹寡聚物实验表明,cZnPc 在孵育的早期阶段增加而不是减少寡聚物的水平。结合测定证实 cZnPc 可以与肽结合。对接模拟表明 Aβ 的寡聚物具有与 cZnPc 更高的相互作用能力。ANS 荧光测定结果表明,cZnPc 不会影响肽的疏水性。然而,在纤维形成条件下孵育 8 小时后,cZnPc 显著增加了肽的固有酪氨酸荧光。重要的是,细胞培养实验表明,cZnPc 在高达 10 µM 的浓度下没有表现出任何毒性。相反,它可以保护神经元细胞系免受 Aβ 诱导的毒性。因此,我们的结果表明,cZnPc 可以影响 Aβ 的聚集过程,使其无毒,这对于阿尔茨海默病的治疗可能至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/fd3379a47669/ijms-25-08931-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/5de34b7f1eb1/ijms-25-08931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/0c4d394d9cd6/ijms-25-08931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/cbc210c2b425/ijms-25-08931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/efb22b7d2d75/ijms-25-08931-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/1829e0f8d960/ijms-25-08931-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/3b69c1973866/ijms-25-08931-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/fd3379a47669/ijms-25-08931-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/5de34b7f1eb1/ijms-25-08931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/0c4d394d9cd6/ijms-25-08931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/cbc210c2b425/ijms-25-08931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/efb22b7d2d75/ijms-25-08931-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/1829e0f8d960/ijms-25-08931-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/3b69c1973866/ijms-25-08931-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243f/11354870/fd3379a47669/ijms-25-08931-g007.jpg

相似文献

1
A Cationic Zn-Phthalocyanine Turns Alzheimer's Amyloid β Aggregates into Non-Toxic Oligomers and Inhibits Neurotoxicity in Culture.一种正电荷锌酞菁将阿尔茨海默病淀粉样β聚集物转化为无毒低聚物并在培养物中抑制神经毒性。
Int J Mol Sci. 2024 Aug 16;25(16):8931. doi: 10.3390/ijms25168931.
2
A Cationic Gallium Phthalocyanine Inhibits Amyloid β Peptide Fibril Formation.一种正电荷镓酞菁抑制淀粉样β肽纤维形成。
Curr Alzheimer Res. 2020;17(7):589-600. doi: 10.2174/1567205017666201008112002.
3
A carboxylated Zn-phthalocyanine inhibits fibril formation of Alzheimer's amyloid β peptide.一种羧基化锌酞菁能抑制阿尔茨海默病淀粉样 β 肽的纤维形成。
FEBS J. 2015 Feb;282(3):463-76. doi: 10.1111/febs.13151. Epub 2014 Dec 15.
4
Nitration of Tyrosine Residue Y10 of Aβ Significantly Inhibits Its Aggregation and Cytotoxicity.β淀粉样蛋白酪氨酸残基Y10的硝化显著抑制其聚集和细胞毒性。
Chem Res Toxicol. 2017 Apr 17;30(4):1085-1092. doi: 10.1021/acs.chemrestox.6b00447. Epub 2017 Mar 15.
5
Binding Modes of Phthalocyanines to Amyloid β Peptide and Their Effects on Amyloid Fibril Formation.与淀粉样β肽结合的酞菁及其对淀粉样纤维形成的影响。
Biophys J. 2018 Mar 13;114(5):1036-1045. doi: 10.1016/j.bpj.2018.01.003.
6
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.姜黄素可抑制β-淀粉样蛋白寡聚体和原纤维的形成,结合斑块,并在体内减少淀粉样蛋白。
J Biol Chem. 2005 Feb 18;280(7):5892-901. doi: 10.1074/jbc.M404751200. Epub 2004 Dec 7.
7
Xanthene food dye, as a modulator of Alzheimer's disease amyloid-beta peptide aggregation and the associated impaired neuronal cell function.香豆素食用染料,作为阿尔茨海默病淀粉样β肽聚集的调节剂和相关受损神经元细胞功能。
PLoS One. 2011;6(10):e25752. doi: 10.1371/journal.pone.0025752. Epub 2011 Oct 5.
8
The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ fibrils in Alzheimer's disease: insight from in-vitro and in-silico studies.β-酪蛋白对阿尔茨海默病中 Aβ 纤维聚集和沉积的潜在抑制作用:来自体外和计算研究的见解。
J Biomol Struct Dyn. 2018 Jun;36(8):2118-2130. doi: 10.1080/07391102.2017.1345326. Epub 2017 Jul 4.
9
Site-specific glycation of Aβ1-42 affects fibril formation and is neurotoxic.Aβ1-42 的位点特异性糖基化会影响纤维形成并具有神经毒性。
J Biol Chem. 2019 May 31;294(22):8806-8818. doi: 10.1074/jbc.RA118.006846. Epub 2019 Apr 17.
10
Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.淀粉样β的无毒构象可能会抑制淀粉样β诱导的大鼠原代神经元毒性:这对于阿尔茨海默病的新型治疗策略具有重要意义。
Biochem Biophys Res Commun. 2013 Aug 16;438(1):1-5. doi: 10.1016/j.bbrc.2013.05.106. Epub 2013 Jun 4.

引用本文的文献

1
Inhibitory Effects of Gliadin Hydrolysates on BACE1 Expression and APP Processing to Prevent Aβ Aggregation.麦醇溶蛋白水解物对β-分泌酶1(BACE1)表达及淀粉样前体蛋白(APP)加工以预防β-淀粉样蛋白(Aβ)聚集的抑制作用
Int J Mol Sci. 2024 Dec 9;25(23):13212. doi: 10.3390/ijms252313212.
2
Mechanism of Metal Complexes in Alzheimer's Disease.金属配合物在阿尔茨海默病中的作用机制。
Int J Mol Sci. 2024 Nov 5;25(22):11873. doi: 10.3390/ijms252211873.

本文引用的文献

1
Disruption of axonal transport in neurodegeneration.神经退行性疾病中轴突运输的中断。
J Clin Invest. 2023 Jun 1;133(11):e168554. doi: 10.1172/JCI168554.
2
Small-molecule theranostics in Alzheimer's disease.阿尔茨海默病的小分子治疗策略。
Eur J Med Chem. 2023 Jul 5;255:115382. doi: 10.1016/j.ejmech.2023.115382. Epub 2023 Apr 21.
3
Analysis of the time-dependent changes of phospholipids in the brain regions of a mouse model of Alzheimer's disease.阿尔茨海默病小鼠模型脑区磷脂随时间变化的分析。
Brain Res. 2023 Feb 1;1800:148197. doi: 10.1016/j.brainres.2022.148197. Epub 2022 Dec 5.
4
Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer's disease pathology.未结合的 PLGA 纳米颗粒可减轻温度依赖性β-淀粉样蛋白聚集,并保护神经元免受毒性侵害:对阿尔茨海默病病理的影响。
J Nanobiotechnology. 2022 Feb 4;20(1):67. doi: 10.1186/s12951-022-01269-0.
5
Roles and Mechanisms of the Protein Quality Control System in Alzheimer's Disease.蛋白质质量控制系统在阿尔茨海默病中的作用和机制。
Int J Mol Sci. 2021 Dec 29;23(1):345. doi: 10.3390/ijms23010345.
6
Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation.小分子介导的淀粉样β寡聚体共组装通过促进非纤维状聚集降低神经毒性。
Chem Sci. 2020 Jun 22;11(27):7158-7169. doi: 10.1039/d0sc00392a.
7
Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease.抗淀粉样蛋白-β单克隆抗体对阿尔茨海默病患者临床和生物标志物结局及不良事件风险的影响:一项系统评价和 III 期 RCT 的荟萃分析
Ageing Res Rev. 2021 Jul;68:101339. doi: 10.1016/j.arr.2021.101339. Epub 2021 Apr 5.
8
Revisiting the Rate-Limiting Step of the ANS-Protein Binding at the Protein Surface and Inside the Hydrophobic Cavity.重新审视蛋白表面和疏水腔体内 ANS-蛋白结合的限速步骤。
Molecules. 2021 Jan 14;26(2):420. doi: 10.3390/molecules26020420.
9
Treatment of Alzheimer's Disease and Blood-Brain Barrier Drug Delivery.阿尔茨海默病的治疗与血脑屏障给药
Pharmaceuticals (Basel). 2020 Nov 16;13(11):394. doi: 10.3390/ph13110394.
10
Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease.小分子结合淀粉样蛋白-β作为阿尔茨海默病的药物发现策略。
Sci Adv. 2020 Nov 4;6(45). doi: 10.1126/sciadv.abb5924. Print 2020 Nov.